LUNG – pulmonx corporation (US:NASDAQ)

News

Pulmonx (NASDAQ:LUNG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 [Yahoo! Finance]
Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
Why The Pulmonx LUNG Narrative Is Shifting After Target Cut And Leadership Return [Yahoo! Finance]
How Leadership Changes And Analyst Revisions Are Shaping Pulmonx's Valuation Story [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com